5th World Congress on Prevention of Diabates
Home
Organizers and co-organizers
Committees
Participants
Programme
Social Programme
Satellite symposia
Corporate partners
Gallery
Contact
5th World Congress on Prevention of Diabates
Travel Venue Discover Helsinki Discover Finland

The WCPD 2008 Congress included two official Satellite Symposia provided by Bayer Schering Pharma and MSD


PROSPECTS FOR THE FUTURE - IS PREVENTION AND TREATMENT OF TYPE 2 DIABETES CHANGING
Provided by MSD

Sunday, June 1st 2008, 12:00 - 14:00
Congress venue, Helsinki Fair Centre, Hall 3 DE
Messuaukio 1, FI-00520 Helsinki


Chairman:  M Laakso, Finland 

Programme:

12:00 - 12:10 Welcome & Introduction
M Laakso, Finland

12:10 - 12:35 Lifestyle and Pharmacological Intervention Studies in Type 2 Diabetes
J Eriksson, Finland

12:35 - 13:00 Incretin Based Therapies in the Treatment of Type 2 Diabetes
C Deacon, Denmark

13:00 - 13:25 Achieving Therapeutic Goals with Sitagliptin - Clinical Data Update
R Carr, Denmark

13:25 - 13:55 Panel Discussion: Prospects for the Future - Is Prevention and Treatment of Type 2 Diabetes Changing

13:55-14:00 Concluding Remarks
M Laakso, Finland



PREVENTING DIABETES AND CARDIOVASCULAR DISEASE - ENTERING A NEW ERA WITH ACARBOSE
Provided by Bayer Schering Pharma

Sunday, 1st June 2008, 12:00 - 14:00

Congress venue, Helsinki Fair Centre, Hall 3 B
Messuaukio 1, FI-00520 Helsinki

Chairman:  J Tuomilehto, Finland

Programme:
 
12:00 – 12:05 Welcome & introduction 
J Tuomilehto, Finland

12:05 – 12:25 Postprandial hyperglycaemia as a driving force in diabetes and CVD – epidemiological evidence & molecular insights
A Ceriello, UK

12:25 – 12:45 Two sides of the same coin – guideline recommendations for managing diabetes and CVD
L Rydén, Sweden

12:45 – 13:05 Screening and intervention programmes to prevent diabetes and CVD – an example from daily practice
I Satman, Turkey

13:05 – 13:25 Acarbose – a safe and effective treatment choice for pre- and established diabetes with cardiovascular benefits 
J-L Chiasson, Canada

13:25 – 13:40 The new Acarbose Cardiovascular Evaluation (ACE) outcome trial – secondary prevention of CVD in prediabetes
R Holman, UK

13:40 – 13:55 Case Study (including electronic voting)
R Holman, UK

13:55 – 14:00 Summary & Close
J Tuomilehto, Finland

 


The WCPD 2008 Satellite Symposia Brochure 


Webmaster Finnish Diabetes Association

 

National Public Health Institute Finnish Diabetes Association DEHKO 2000-2010 FIN-D2D Test your risk for type 2 diabetes